Alkem Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, recommended Final Dividend of 8 per equity share.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories' Board of Directors, at a meeting held on May 29, 2025, has recommended a Final Dividend of ₹8 per equity share for its shareholders. This is a cash dividend payout from the company's profits, subject to shareholder approval at the upcoming Annual General Meeting (AGM). The dividend amount is in line with the company's prior-year final dividend, indicating a stable payout policy. The record date for eligibility and the payment timeline will be communicated separately by the company.
This is a routine final dividend declaration and is unlikely to have a significant impact on the stock price. Shareholders holding shares as of the record date will receive ₹8 per share as cash, representing a modest yield given Alkem's current share price levels.